Isoliquiritigenin Attenuates UUO-Induced Renal Inflammation and Fibrosis by Inhibiting Mincle/Syk/NF-Kappa B Signaling Pathway

PURPOSE: Chronic kidney disease (CKD) is a global nephrotic syndrome characterized by chronic inflammation, oxidative stress and fibrosis in the kidney. Isoliquiritigenin (ISL), a flavonoid from licorice, has historically been reported to inhibit innate immune responses to inflammation and fibrosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Yuan, Tan, Rui-zhi, Li, Jian-chun, Liu, Tong-tong, Zhong, Xia, Yan, Ying, Yang, Jie-ke, Lin, Xiao, Fan, Jun-ming, Wang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7166058/
https://www.ncbi.nlm.nih.gov/pubmed/32341639
http://dx.doi.org/10.2147/DDDT.S243420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7166058/
https://www.ncbi.nlm.nih.gov/pubmed/32341639
http://dx.doi.org/10.2147/DDDT.S243420

Ejemplares similares